Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | Director · President & CEO | February 08, 2024 | February 12, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date February 08, 2024 · Filed February 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 46,254 |
Reported balance
After 2024-02-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-02-08 · Grant · Acquired 46,254 · Balance 46,254 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: 46,254 shares will vest in equal installments on February 8, 2025, February 8, 2026 and February 8, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2: 46,254 shares will vest in equal installments on February 8, 2025, February 8, 2026 and February 8, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 1
1 source rowRow 1 · 2022-05-27 · Disposition to issuer · Disposed 505,926 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $15.40 · Expires 2026-02-10 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-27 · Disposition to issuer · Disposed 23,461 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $21.08 · Expires 2027-02-15 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-27 · Disposition to issuer · Disposed 20,249 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Disposition to issuer · Disposed 27,637 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 37,440 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 28,080 shares are vested in full; 9,360 shares will vest on February 4, 2023. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $77.16 · Expires 2030-02-03 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 30,358 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 15,180 shares are vested in full; the remaining 15,178 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $228.21 · Expires 2030-08-24 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 10,593 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6: 3,531 shares are vested in full; the remaining 7,062 shares will vest in equal installments on August 24, 2022 and August 24, 2023. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 8,924 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 2,231 shares are vested in full; the remaining 6,693 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $142.45 · Expires 2031-07-28 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 11,140 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 3,713 shares will vest on July 28, 2022; 3,713 shares will vest on July 28, 2023; and 3,714 shares will vest on July 28, 2024. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 27,043 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 18,720 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 18,720 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 7,309 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 2,192 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-05-27 · Disposition to issuer · Disposed 7,590 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 7,590 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-05-27 · Disposition to issuer · Disposed 2,921 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 1,460 shares will vest on August 24, 2022 and 1,461 shares will vest on August 24, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2022-05-27 · Disposition to issuer · Disposed 3,347 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 1,115 shares will vest on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2022-05-27 · Disposition to issuer · Disposed 27,043 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F17: 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2022-05-27 · Disposition to issuer · Disposed 24,187 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F18: 12,093 shares will vest on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2022-05-27 · Disposition to issuer · Disposed 2,646 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2022-05-27 · Disposition to issuer · Disposed 794 · Balance 0 F10: Each restricted stock unit represents the right to receive one share of Quidel common stock. F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F19: 794 shares will vest on January 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3: Vested in full.
F4: 28,080 shares are vested in full; 9,360 shares will vest on February 4, 2023.
F5: 15,180 shares are vested in full; the remaining 15,178 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F6: 3,531 shares are vested in full; the remaining 7,062 shares will vest in equal installments on August 24, 2022 and August 24, 2023.
F7: 2,231 shares are vested in full; the remaining 6,693 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F8: 3,713 shares will vest on July 28, 2022; 3,713 shares will vest on July 28, 2023; and 3,714 shares will vest on July 28, 2024.
F9: 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
F10: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F11: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F12: 18,720 shares will vest on February 4, 2023.
F13: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F14: 7,590 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F15: 1,460 shares will vest on August 24, 2022 and 1,461 shares will vest on August 24, 2023.
F16: 1,115 shares will vest on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025.
F17: 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
F18: 12,093 shares will vest on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
F19: 794 shares will vest on January 31, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2022 Filed Jan 19, 2022 20:00 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 6,911 | $114.88 | $793,935.68 |
DisclosureSEC source: 0001209191-22-003870 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,451 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 16, 2022 Filed Jan 19, 2022 20:00 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 13,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003870 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,362 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-053551 · doc4.xml · derivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,921 Underlying: Common Stock · 1,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F4 · derivative.exercise_date: 1,460 shares vested on August 24, 2021; 1,460 shares will vest on August 24, 2022; and 1,461 shares will vest on August 24, 2023. F4 · derivative.expiration_date: 1,460 shares vested on August 24, 2021; 1,460 shares will vest on August 24, 2022; and 1,461 shares will vest on August 24, 2023. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 724 | $121.80 | $88,183.20 |
DisclosureSEC source: 0001209191-21-053551 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,543 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-053551 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,267 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:11 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stock Options · Derivative | 11,140 | $0.00 Strike: $142.45 | $0.00 |
DisclosureSEC source: 0001209191-21-048973 · doc4.xml · derivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,140 Underlying: Common Stock · 11,140 shares Expires 2031-07-28 F1 · derivative.exercise_date: 3,713 shares will vest on the first anniversary of the grant date, July 28, 2022; 3,713 shares will vest on the second anniversary of the grant date, July 28, 2023; and 3,714 shares will vest on the third anniversary of the grant date, July 28, 2024. Read SEC document |
| February 22, 2021 Filed Feb 22, 2021 19:40 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | PurchaseCommon Stock | 5,000 | $165.30 | $826,500.00 |
DisclosureSEC source: 0001209191-21-012937 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,807 F1 · price: The weighted average purchase price for these transactions was $165.30 per share, with a range of $163.13 to $167.91 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 9,282 | $210.10 | $1,950,148.20 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 8 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,807 F4 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 18,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 7 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,089 F5 · shares: Reporting person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 02/04/2019. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 6,851 | $210.10 | $1,439,395.10 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 6 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,369 F4 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 13,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 5 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,220 F3 · shares: Reporting person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 01/16/2018. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 2,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · derivative · entry 10 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.expiration_date: The shares of common stock issued pursuant to the release of these restricted stock units were released pursuant to deferral periods defined under the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 9,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · derivative · entry 9 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.expiration_date: The shares of common stock issued pursuant to the release of these restricted stock units were released pursuant to deferral periods defined under the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 1,393 | $217.79 | $303,381.47 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 4 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,402 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 2,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,795 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 4,423 | $217.79 | $963,285.17 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,987 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:15 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 9,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012552 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,410 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 20:29 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 20,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011582 · doc4.xml · derivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 20,250 shares vested on the fourth anniversary date of the grant date, February 15, 2021. F5 · derivative.expiration_date: 20,250 shares vested on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 20:29 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 10,040 | $227.97 | $2,288,818.80 |
DisclosureSEC source: 0001209191-21-011582 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,047 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 20:29 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 20,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011582 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,087 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 101 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 18:47 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 3,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008292 · doc4.xml · derivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,385 Underlying: Common Stock · 3,795 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 3,795 shares vested on the first anniversary date of the grant date, February 3, 2021. F4 · derivative.expiration_date: 3,795 shares vested on the first anniversary date of the grant date, February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 18:47 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 1,882 | $236.85 | $445,751.70 |
DisclosureSEC source: 0001209191-21-008292 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,736 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 18:47 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 3,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008292 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,618 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 20:42 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stock Option · Derivative | 8,924 | $0.00 Strike: $254.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007590 · doc4.xml · derivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,924 Underlying: Common Stock · 8,924 shares Expires 2031-02-01 F2 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 20:42 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 4,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007590 · doc4.xml · derivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,462 Underlying: Common Stock · 4,462 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. F2 · derivative.expiration_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 18:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | PurchaseCommon Stock | 5,000 | $174.99 | $874,965.00 |
DisclosureSEC source: 0001209191-20-048969 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,823 F1 · price: The weighted average purchase price for these transactions was $174.993 per share, with a range of $168.41 to $177.51 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:30 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stock Options · Derivative | 10,593 | $0.00 Strike: $228.21 | $0.00 |
DisclosureSEC source: 0001209191-20-048471 · doc4.xml · derivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,593 Underlying: Common Stock · 10,593 shares Expires 2030-08-24 F3 · derivative.exercise_date: 3,531 shares will vest on first anniversary date of the grant date, August 24, 2021; 3,531 shares will vest on the second anniversary date of the grant date, August 24, 2022; and 3,531 share will vest on the third anniversary date of the grant date, August 24, 2023. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:30 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 4,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048471 · doc4.xml · derivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 Underlying: Common Stock · 4,381 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: 1,460 shares will vest on August 24, 2021; 1,460 shares will vest on August 24, 2022; and 1,461 shares will vest on August 24, 2023. F2 · derivative.expiration_date: 1,460 shares will vest on August 24, 2021; 1,460 shares will vest on August 24, 2022; and 1,461 shares will vest on August 24, 2023. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:38 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | PurchaseCommon Stock | 5,000 | $234.12 | $1,170,600.00 |
DisclosureSEC source: 0001209191-20-046254 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,823 F1 · price: The weighted average purchase price for these transactions was $234.12 per share, with a range of $229.44 to $242.15 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 17:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | PurchaseCommon Stock | 5,000 | $160.33 | $801,670.00 |
DisclosureSEC source: 0001209191-20-036379 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,823 F1 · price: The weighted average purchase price for these transactions was $160.334 per share, with a range of $158.56 to $164.32 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,582 | $80.40 | $207,592.80 |
DisclosureSEC source: 0001209191-20-010818 · doc4.xml · nonDerivative · entry 4 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,415 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. F3 · balance_after: The amount of securities beneficially owned following this transaction includes an additional 413 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 5,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010818 · doc4.xml · nonDerivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,584 F1 · shares: Reflects vesting of restricted stock units which were previously reported on a Form 4. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 8,606 | $80.40 | $691,922.40 |
DisclosureSEC source: 0001209191-20-010818 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,378 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 17,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010818 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,984 F1 · shares: Reflects vesting of restricted stock units which were previously reported on a Form 4. Read SEC document |
| February 16, 2020 Filed Feb 24, 2020 20:02 UTC Amendment | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 8,198 | $80.40 | $659,119.20 |
DisclosureSEC source: 0001209191-20-012285 · doc4a.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,823 F1 · shares: On February 19, 2020, the Reporting Person filed a Form 4 which reported the disposition of 8,606 shares in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon the release of restricted stock units. Due to a clerical error, the number of shares reported as withheld was incorrectly calculated and reported. The correct amount of shares withheld was 8,198. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:04 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 1,589 | $77.52 | $123,179.28 |
DisclosureSEC source: 0001209191-20-009027 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,628 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:04 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 3,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009027 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,217 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 20:25 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Unit · Derivative | 15,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007061 · doc4.xml · derivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,180 Underlying: Common Stock · 15,180 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F1 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. F1 · derivative.expiration_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 20:25 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stockk Options · Derivative | 30,358 | $0.00 Strike: $77.16 | $0.00 |
DisclosureSEC source: 0001209191-20-007061 · doc4.xml · derivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,358 Underlying: Common Stock · 30,358 shares Expires 2030-02-03 F1 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 20,250 | $0.00 Strike: $21.08 | $0.00 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · derivative · entry 13 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,249 Underlying: Common Stock · 20,250 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 20,250 shares vested on the second anniversary date of the grant date, February 15, 2019. 10,125 shares will vest on the third anniversary date of the grant date, February 15, 2020. 10,124 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 70,386 | $0.00 Strike: $15.40 | $0.00 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · derivative · entry 12 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,461 Underlying: Common Stock · 70,386 shares Expires 2026-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 46,924 shares vested on the second anniversary date of the grant date, February 10, 2018. 23,462 shares vested on the third anniversary date of the grant date, February 10, 2019. 23,461 shares will vest on the fourth anniversary date of the grant date, February 10, 2020. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 93,847 | $0.00 Strike: $23.41 | $0.00 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · derivative · entry 11 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 93,847 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 46,924 shares vested on the second anniversary date of the grant date, February 5, 2017. 23,462 shares vested on the third anniversary date of the grant date, February 5, 2018. 23,461 shares vested on the fourth anniversary date of the grant date, February 5, 2019. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 93,021 | $0.00 Strike: $27.57 | $0.00 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · derivative · entry 10 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 93,021 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 46,510 shares vested on the second anniversary date of the grant date, February 24, 2016. 23,255 shares vested on the third anniversary date of the grant date, February 23, 2017. 23,256 shares vested on the fourth anniversary date of the grant date, February 24, 2018. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualifed Stock Options · Derivative | 96,217 | $0.00 Strike: $22.21 | $0.00 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · derivative · entry 9 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,217 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 48,109 shares vested on the second anniversary date of the grant date, February 25, 2015. 24,054 shares vested on the third anniversary date of the grant date, February 25, 2016. 24,054 shares vested on the fourth anniversary date of the grant date, February 25, 2017. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 4,023 | $0.00 Strike: $15.19 | $0.00 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · derivative · entry 8 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,023 shares Expires 2022-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 60,196 shares vested on the second anniversary date of the grant date, March 2, 2014. 30,098 shares vested on the third anniversary date of the grant date, March 2, 2015. 30,099 shares vested on the fourth anniversary date of the grant date, March 2, 2016. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 252,173 | $65.82 | $16,598,026.86 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · nonDerivative · entry 7 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,013 F1 · kind: On November 20, 2019, the reporting person exercised options to acquire 377,744 shares of the Issuer's common stock. Also on November 20, 2019, as permitted by the option award agreements, the reporting person delivered 128,695 shares of the Issuer's common stock owned by the reporting person and having a fair market value on the date of exercise equal to the aggregate option exercise price and 123,478 shares of the issuer's common stock owned by the reporting person and having a fair market value of the date of exercise equal to the reporting person's tax withholding obligation. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 20,250 | $21.08 | $426,870.00 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · nonDerivative · entry 6 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 679,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 70,386 | $15.40 | $1,083,944.40 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · nonDerivative · entry 5 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 93,847 | $23.41 | $2,196,958.27 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · nonDerivative · entry 4 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 20:03 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 93,021 | $27.57 | $2,564,588.97 |
DisclosureSEC source: 0001209191-19-057878 · doc4.xml · nonDerivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.